Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)
CNY 14.12
(-0.14%)
CNY 14.12
(-0.14%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.18 Billion CNY | -4.01% |
| 2022 | 5.4 Billion CNY | 41.05% |
| 2021 | 3.83 Billion CNY | 49.19% |
| 2020 | 2.56 Billion CNY | 130.02% |
| 2019 | 1.11 Billion CNY | 12.41% |
| 2018 | 993.55 Million CNY | 28.11% |
| 2017 | 775.58 Million CNY | -15.5% |
| 2016 | 917.82 Million CNY | 4.35% |
| 2015 | 879.55 Million CNY | 64.77% |
| 2014 | 533.8 Million CNY | 33.55% |
| 2013 | 399.69 Million CNY | 24.61% |
| 2012 | 320.75 Million CNY | -38.76% |
| 2011 | 523.77 Million CNY | -22.98% |
| 2010 | 680.07 Million CNY | -5.4% |
| 2009 | 718.89 Million CNY | 106.65% |
| 2008 | 347.87 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 5.12 Billion CNY | 0.1% |
| 2024 Q2 | 5.12 Billion CNY | -4.92% |
| 2024 Q1 | 5.38 Billion CNY | 3.85% |
| 2023 FY | 5.18 Billion CNY | -4.01% |
| 2023 Q2 | 6.45 Billion CNY | 5.59% |
| 2023 Q4 | 5.18 Billion CNY | -7.12% |
| 2023 Q3 | 5.58 Billion CNY | -13.47% |
| 2023 Q1 | 6.11 Billion CNY | 13.11% |
| 2022 Q3 | 4.93 Billion CNY | 3.67% |
| 2022 Q1 | 4.29 Billion CNY | 12.11% |
| 2022 Q4 | 5.4 Billion CNY | 9.44% |
| 2022 Q2 | 4.76 Billion CNY | 10.89% |
| 2022 FY | 5.4 Billion CNY | 41.05% |
| 2021 Q3 | 4.03 Billion CNY | -27.2% |
| 2021 FY | 3.83 Billion CNY | 49.19% |
| 2021 Q1 | 3.91 Billion CNY | 52.25% |
| 2021 Q2 | 5.53 Billion CNY | 41.57% |
| 2021 Q4 | 3.83 Billion CNY | -4.93% |
| 2020 FY | 2.56 Billion CNY | 130.02% |
| 2020 Q4 | 2.56 Billion CNY | 29.09% |
| 2020 Q1 | 1.43 Billion CNY | 28.52% |
| 2020 Q2 | 1.69 Billion CNY | 18.39% |
| 2020 Q3 | 1.99 Billion CNY | 17.11% |
| 2019 Q3 | 987.96 Million CNY | -0.63% |
| 2019 Q1 | 1.01 Billion CNY | 2.65% |
| 2019 FY | 1.11 Billion CNY | 12.41% |
| 2019 Q4 | 1.11 Billion CNY | 13.05% |
| 2019 Q2 | 994.18 Million CNY | -2.52% |
| 2018 FY | 993.55 Million CNY | 28.11% |
| 2018 Q4 | 993.55 Million CNY | 13.12% |
| 2018 Q3 | 878.3 Million CNY | 3.0% |
| 2018 Q2 | 852.73 Million CNY | 12.35% |
| 2018 Q1 | 759.02 Million CNY | -2.14% |
| 2017 Q2 | 1.13 Billion CNY | 1.84% |
| 2017 Q1 | 1.11 Billion CNY | 21.45% |
| 2017 Q4 | 775.58 Million CNY | -2.59% |
| 2017 FY | 775.58 Million CNY | -15.5% |
| 2017 Q3 | 796.18 Million CNY | -29.86% |
| 2016 Q2 | 1.02 Billion CNY | 22.22% |
| 2016 Q3 | 1.07 Billion CNY | 5.47% |
| 2016 Q4 | 917.82 Million CNY | -14.87% |
| 2016 FY | 917.82 Million CNY | 4.35% |
| 2016 Q1 | 836.33 Million CNY | -4.91% |
| 2015 Q3 | 941.37 Million CNY | 21.64% |
| 2015 FY | 879.55 Million CNY | 64.77% |
| 2015 Q2 | 773.89 Million CNY | 56.8% |
| 2015 Q1 | 493.56 Million CNY | -7.54% |
| 2015 Q4 | 879.55 Million CNY | -6.57% |
| 2014 Q3 | 532.22 Million CNY | -9.59% |
| 2014 FY | 533.8 Million CNY | 33.55% |
| 2014 Q4 | 533.8 Million CNY | 0.3% |
| 2014 Q2 | 588.7 Million CNY | 28.0% |
| 2014 Q1 | 459.92 Million CNY | 15.07% |
| 2013 Q4 | 399.69 Million CNY | -16.98% |
| 2013 FY | 399.69 Million CNY | 24.61% |
| 2013 Q1 | 409.55 Million CNY | 27.69% |
| 2013 Q2 | 427.45 Million CNY | 4.37% |
| 2013 Q3 | 481.45 Million CNY | 12.64% |
| 2012 Q4 | 320.75 Million CNY | -35.94% |
| 2012 Q1 | 490 Million CNY | -6.45% |
| 2012 Q2 | 439.76 Million CNY | -10.25% |
| 2012 Q3 | 500.73 Million CNY | 13.86% |
| 2012 FY | 320.75 Million CNY | -38.76% |
| 2011 FY | 523.77 Million CNY | -22.98% |
| 2011 Q2 | 626.86 Million CNY | 0.0% |
| 2011 Q3 | 618.72 Million CNY | -1.3% |
| 2011 Q4 | 523.77 Million CNY | -15.35% |
| 2010 Q4 | 680.07 Million CNY | 0.0% |
| 2010 FY | 680.07 Million CNY | -5.4% |
| 2009 FY | 718.89 Million CNY | 106.65% |
| 2008 FY | 347.87 Million CNY | 0.0% |